PXD033655
PXD033655 is an original dataset announced via ProteomeXchange.
Dataset Summary
Title | Proteomic analysis of patients with advanced triple-negative breast cancer |
Description | In the later-line setting or for patients with PD-L1-negative tumors, immunotherapy-based regimens remain ineffective against advanced triple-negative breast cancer (TNBC). In this multicentered phase II trial (NCT04303741), 46 patients with pretreated advanced TNBC were enrolled to receive camrelizumab 200 mg (day 1), and apatinib 250 mg daily, plus eribulin 1.4 mg/m2 (day 1 and 8) on a 21-day cycle until progression, or unacceptable toxicity. We performed correlation analysis between the patient's baseline protein expression level and curative effect. |
HostingRepository | iProX |
AnnounceDate | 2022-05-04 |
AnnouncementXML | Submission_2022-06-09_00:53:58.343.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Zhenluan Tian |
SpeciesList | scientific name: Homo sapiens; NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | Q Exactive HF |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
---|---|---|---|
0 | 2022-05-04 18:50:56 | ID requested | |
1 | 2022-05-04 18:51:48 | announced | |
⏵ 2 | 2022-06-09 00:53:59 | announced | 2022-06-09: Update publication information. |
Publication List
Liu J, Wang Y, Tian Z, Lin Y, Li H, Zhu Z, Liu Q, Su S, Zeng Y, Jia W, Yang Y, Xu S, Yao H, Jiang W, Song E, Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer. Nat Commun, 13(1):3011(2022) [pubmed] |
Keyword List
submitter keyword: Breast cancer |
Contact List
Jieqiong Liu | |
---|---|
contact affiliation | Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
contact email | liujieqiong01@163.com |
lab head | |
Zhenluan Tian | |
contact affiliation | Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
contact email | 1339087943@qq.com |
dataset submitter |
Full Dataset Link List
iProX dataset URI |